| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pediatrics, "F. Fede" Seconda Università degli Studi di Napoli, 80138 Napoli, Italy
Address all correspondence and requests for reprints to: Dr. Emanuele Miraglia del Giudice, Dipartimento di Pediatria, Seconda Università di Napoli, Via Luigi De Crecchio No. 2, 80138 Napoli, Italy. E-mail: emanuele.miraglia{at}unina2.it.
Objective: The insulin variable number of tandem repeats (VNTR) polymorphism located in the insulin gene promoter (INS VNTR) has been associated with insulin levels in obese children. Hyperinsulinemia is a pivotal factor in the development of metabolic syndrome, an emerging complication in childhood obesity. With the present study, we aimed to test the associations between INS VNTR and the metabolic syndrome in juvenile-onset obesity.
Subjects and Methods: We screened for the INS VNTR in 320 obese children (152 girls; mean age, 11.2 ± 2.3 yr; mean z-score body mass index, 3.6 ± 1.1). All of them underwent a standard oral glucose tolerance test; baseline measurements included blood pressure and plasma lipid and fasting insulin levels. By using the data derived from the oral glucose tolerance test, the whole-body insulin sensitivity and the insulinogenic index were calculated.
Results: The prevalence of metabolic syndrome reached 39%. No differences in INS VNTR genotype distribution were observed between obese subjects and 200 lean, age- and sex-matched children (P = 0.7). Among obese subjects, the prevalence of the metabolic syndrome was significantly higher in subjects with the I/I genotype (P = 0.006); the risk for developing the metabolic syndrome was significantly higher in subjects carrying the I/I genotype (odds ratio, 2.5; 95% confidence interval, 1.53.9). Obese subjects homozygous for the class I allele showed higher insulin levels and insulinogenic index but lower whole-body insulin sensitivity.
Conclusions: We conclude that the I variant of the insulin promoter, when expressed in homozygotes, can predispose obese children to develop the metabolic syndrome.
This article has been cited by other articles:
![]() |
C. Le Stunff, A. Dechartres, V. Mariot, C. Lotton, C. Trainor, E. Miraglia Del Giudice, D. Meyre, I. Bieche, I. Laurendeau, P. Froguel, et al. Association Analysis Indicates That a Variant GATA-Binding Site in the PIK3CB Promoter Is a Cis-Acting Expression Quantitative Trait Locus for This Gene and Attenuates Insulin Resistance in Obese Children Diabetes, February 1, 2008; 57(2): 494 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Le Stunff, A. Dechartres, E. Miraglia Del Giudice, P. Froguel, and P. Bougneres A Single-Nucleotide Polymorphism in the p110 Gene Promoter Is Associated with Partial Protection from Insulin Resistance in Severely Obese Adolescents J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 212 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O Mook-Kanamori, J J Miranda Geelhoed, E. A P Steegers, J. C M Witteman, A. Hofman, H. A Moll, C. M van Duijn, A. C S Hokken-Koelega, and V. W V Jaddoe Insulin gene variable number of tandem repeats is not associated with weight from fetal life until infancy: the Generation R Study Eur. J. Endocrinol., December 1, 2007; 157(6): 741 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bougneres Genotypic and phenotypic complexity at the insulin variable number of tandem repeats locus. J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4246 - 4249. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |